TET2 and hepatocellular carcinoma: In summary, this study shows that the downregulation of XIST expression can lead to poor prognosis in female HCC, and TET2 can form a complex with YY1 and bind to the XIST promoter region, maintain the hypomethylation of this region, as well as promote XIST expression.